Oncology

Featured Tests:

  • 17-Ketosteroids, Urine
  • 1p/19q Deletion by FISH
  • 5'Nucleotidase, Serum
  • 5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 5 Mutations
  • 5-Hydroxyindoleacetic Acid (HIAA), Urine
  • Acid Hemolysin (Ham Test)Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Acute Lymphocytic Leukemia (ALL) Panel by FISH, Adult
  • Acute Lymphocytic Leukemia (ALL) Panel by FISH, Pediatric
  • Acute Myelogenous Leukemia (AML) with Myelodysplastic Syndrome (MDS), or Therapy-Related AML, by FISH
  • Acute Myelogenous Leukemia Panel by FISH
  • Adrenocorticotropic Hormone (ACTH) by Immunohistochemistry
  • Adrenocorticotropic Hormone, Plasma
  • Pan Cytokeratin (AE1,3) by Immunohistochemistry
  • Aggressive B-Cell Lymphoma FISH Reflex, Tissue
  • ALK (D5F3) by Immunohistochemistry with Reflex to ALK Gene Rearrangements by FISH
  • ALK (D5F3) with Interpretation by Immunohistochemistry
  • ALK Gene Rearrangements in NSCLC for Crizotinib Eligibility by FISH
  • Alkaline Phosphatase Isoenzymes, Serum or Plasma
  • Alkaline Phosphatase, Serum or Plasma
  • Alpha Fetoprotein, Plasma or Serum (Tumor Marker)
  • Alpha Fetoprotein, Total and L3 Percent
  • Alpha-1-Antichymotrypsin (A1ACT) by Immunohistochemistry
  • Alpha-1-Fetoprotein (AFP) by Immunohistochemistry
  • Anaplastic Lymphoma Kinase 1 (ALK-1) by Immunohistochemistry
  • Angiotensin Converting Enzyme, Serum
  • Arginase 1 by Immunohistochemistry
  • Arginine Vasopressin Hormone, Plasma
  • B Cell Specific Octamer Binding Protein-1 (BOB-1) by Immunohistochemistry
  • B-Cell CD20 Expression
  • B-Cell Clonality Screening (IgH and IgK) by PCR
  • BCL-2 by Immunohistochemistry
  • BCL-6 by Immunohistochemistry
  • BCR-ABL1 Mutation Analysis by Next Generation Sequencing
  • BCR-ABL1, Major (p210), Quantitative
  • BCR-ABL1, Minor (p190), Quantitative
  • BCR-ABL1, Qualitative with Reflex to BCR-ABL1 Quantitative
  • Bence Jones Protein, Qualitative Free Kappa and Lambda Light Chains, Urine
  • Bence Jones Protein, Quantitative Free Kappa and Lambda Light Chains, Urine
  • Anti-Human Epithelial Antigen, Ber-EP4 by Immunohistochemistry
  • Beta-2 Microglobulin, Serum or Plasma
  • Beta-Catenin-1 by Immunohistochemistry
  • Beta-hCG, Serum Quantitative (Tumor Marker)
  • BF-1 by Immunohistochemistry
  • Bladder Tumor Associated Antigen
  • Bone Marrow Failure Sequencing, 35 Genes
  • Bone Marrow, Chromosome Analysis with Reflex to Genomic Microarray
  • Bone Specific Alkaline Phosphatase, Serum
  • BRAF codon 600 Mutation Detection by Pyrosequencing
  • BRAF Codon 600 Mutation Detection with Reflex to MLH1 Promoter Methylation
  • BRAF V600E Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
  • BRAF V600E Mutation Detection in Hairy Cell Leukemia by Real-Time PCR, Quantitative
  • Breast 2 (GCDFP-15) by Immunohistochemistry
  • Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 20 Genes
  • Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing
  • Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing and Deletion/Duplication
  • Breast Carcinoma b72.3 by Immunohistochemistry
  • c-MET by Immunohistochemistry
  • C-MYC by Immunohistochemistry
  • C-Peptide, Serum or Plasma
  • Calcitonin by Immunohistochemistry
  • Calcitonin, Serum or Plasma
  • Caldesmon by Immunohistochemistry
  • CALR (Calreticulin) Exon 9 Mutation Analysis by PCR
  • Calretinin by Immunohistochemistry
  • Cancer Antigen 125 by Immunohistochemistry
  • Cancer Antigen 125, Serum or Plasma
  • Cancer Antigen 27.29, Serum
  • Cancer Antigen-Breast (CA 15-3), Serum or Plasma
  • Cancer Antigen-GI (CA 19-9), Body Fluid
  • Cancer Antigen-GI (CA 19-9), Serum or Plasma
  • Cancer Panel, Hereditary, Deletion/Duplication, 46 Genes
  • Cancer Panel, Hereditary, Sequencing and Deletion/Duplication, 47 Genes
  • Carcinoembryonic Antigen, Fluid
  • Carcinoembryonic Antigen, Monoclonal (CEA M) by Immunohistochemistry
  • Carcinoembryonic Antigen, Polyclonal (CEA P) by Immunohistochemistry
  • Carcinoembryonic Antigen, Serum
  • Carotenes, Fractionated, Plasma or Serum
  • Catecholamines Fractionated by LC-MS/MS, Urine Free
  • Catecholamines Fractionated, Plasma
  • CBFB-MYH11 inv(16) Detection, Quantitative
  • CD10 (CALLA) by Immunohistochemistry
  • CD117 (c-Kit) by Immunohistochemistry
  • CD138 (Syndecan-1) by Immunohistochemistry
  • CD14 by Immunohistochemistry
  • CD15, Leu M1 by Immunohistochemistry
  • CD19 by Immunohistochemistry
  • CD1a by Immunohistochemistry
  • CD2 by Immunohistochemistry
  • CD20, L26 by Immunohistochemistry
  • CD21 (Dendritic Cell) by Immunohistochemistry
  • CD23 by Immunohistochemistry
  • CD25 by Immunohistochemistry
  • CD3 by Immunohistochemistry
  • CD30 (Ki-1) by Immunohistochemistry
  • CD33 by Immunohistochemistry
  • CD34, QBEnd/10 by Immunohistochemistry
  • CD35 by Immunohistochemistry
  • CD4 by Immunohistochemistry
  • CD42b by Immunohistochemistry
  • CD43, L60 (Leu 22) by Immunohistochemistry
  • CD44 by Immunohistochemistry
  • CD45 by Immunohistochemistry
  • CD5 by Immunohistochemistry
  • CD52 (CAMPATH-1) by Immunohistochemistry
  • CD56 (NCAM) by Immunohistochemistry
  • CD57 by Immunohistochemistry
  • CD61 (Platelet Glycoprotein IIIA) by Immunohistochemistry
  • CD68, KP1 by Immunohistochemistry
  • CD7 by Immunohistochemistry
  • CD79A by Immunohistochemistry
  • CD8 by Immunohistochemistry
  • CDK4 by Immunohistochemistry
  • CDX2 by Immunohistochemistry
  • CEBPA Mutation Detection
  • Central Nervous System Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes
  • Chromogranin A by Immunohistochemistry
  • Chromogranin A, Serum
  • Chromosome Analysis, Bone Marrow
  • Chromosome Analysis, Leukemic Blood
  • Chromosome Analysis, Peripheral Blood
  • Chromosome Analysis, Solid Tumor
  • Chromosome FISH, CLL Panel
  • Chromosome FISH, Interphase
  • Chromosome FISH, Multiple Myeloma Panel Process and Hold
  • Circulating Tumor Cell Count
  • Colon Cancer Gene Panel, Somatic
  • Creatine Kinase Isoenzymes, Serum
  • CXCL13 by Immunohistochemistry
  • Cyclic AMP, Urine
  • Cyclin D1, SP4 by Immunohistochemistry
  • Cytochrome P450 2C19, CYP2C19 - 9 Variants
  • Cytochrome P450 2C9, CYP2C9 - 2 Variants
  • Cytochrome P450 2D6 (CYP2D6) 14 Mutations and Gene Duplication
  • Cytochrome P450 Genotype Panel
  • Cytogenomic Molecular Inversion Probe Array, Copy Number and Heterozygosity Assessment - Formalin-Fixed Paraffin-Embedded (FFPE) Tissue
  • Cytogenomic SNP Microarray—Oncology
  • Cytokeratin 19 (CK 19) by Immunohistochemistry
  • Cytokeratin 19 Fragment (CYFRA 21-1), Serum
  • Cytokeratin 20 (CK 20) by Immunohistochemistry
  • Cytokeratin 5,6 (CK 5,6) by Immunohistochemistry
  • Cytokeratin 7 (CK 7) by Immunohistochemistry
  • Cytokeratin 8,18 Low Molecular Weight (CAM 5.2) by Immunohistochemistry
  • Cytokine Panel 12 by MAFD, Serum or Plasma
  • Cytology, Fine Needle Aspirate
  • Cytology, Non-Gynecologic
  • Cytology, SurePath Liquid-Based Pap
  • Cytology, SurePath Liquid-Based Pap Test and Human Papillomavirus (HPV), High Risk by Hybrid Capture (for routine co-testing in women over 30)
  • Cytology, SurePath Liquid-Based Pap Test with Reflex to Human Papillomavirus (HPV) DNA Probe, High Risk
  • Cytology, ThinPrep Pap Test and Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
  • Cytology, ThinPrep® Pap Test
  • Cytology, ThinPrep® Pap Test with Reflex to Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
  • Cytomegalovirus Antibody, IgG, Serum
  • D2-40 by Immunohistochemistry
  • DDIT3 (CHOP) (12q13) Gene Rearrangement by FISH
  • Dehydroepiandrosterone Sulfate, Serum or Plasma
  • Des-gamma-carboxy Prothrombin, Serum
  • Desmin by Immunohistochemistry
  • Dihydropyrimidine Dehydrogenase (DPYD) Genotyping, 3 Mutations
  • DNA Content/Cell Cycle Analysis, Miscellaneous
  • DOG1 by Immunohistochemistry
  • E-Cadherin by Immunohistochemistry
  • EGFR by FISH
  • EGFR Mutation Detection by Pyrosequencing
  • EGFR T790M Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
  • EIF2AK4-Associated Disorders (EIF2AK4) Sequencing
  • Endocrine Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 13 Genes
  • Eosinophilia Panel by FISH
  • Epi proColon
  • Epithelial Membrane Antigen (EMA) by Immunohistochemistry
  • Epithelial-related Antigen, MOC-31 by Immunohistochemistry
  • Epstein-Barr Virus (EBV) by in situ Hybridization, Paraffin
  • Epstein-Barr Virus, Quantitative PCR
  • ERBB2 (HER-2/neu) Gene Amplification by FISH, Tissue
  • ERBB2 (HER2)(HercepTest) by Immunohistochemistry
  • ERBB2 (HercepTest®) by Immunohistochemistry, Tissue with Reflex to FISH if 2+
  • ERBB2 (HercepTest®) with Interpretation by Immunohistochemistry, Tissue
  • Erythropietin, Serum or Plasma
  • Esterase Stain, Nonspecific
  • Estradiol, Serum, Adult Premenopausal Female, Serum or Plasma
  • Estrogen Receptor (ER) by Immunohistochemistry
  • Estrogen/Progesterone Receptor with Interpretation by Immunohistochemistry
  • Ewing Sarcoma (O13) by Immunohistochemistry
  • EWSR1 (22q12) Gene Rearrangement by FISH
  • Factor XIIIa by Immunohistochemistry
  • Familial Adenomatous Polyposis (APC) Sequencing
  • Familial Adenomatous Polyposis Panel: APC Sequencing, APC Deletion/Duplication, and MYH 2 Mutations
  • Familial Mutation, Targeted Sequencing
  • FLT3 Mutation Detection by PCR
  • FLT3 Signal Ratio Mutation Detection by PCR
  • Follicle Stimulating Hormone, Serum
  • FOXO1 (FKHR) (13q14) Gene Rearrangement by FISH
  • Friend Leukemia Integration-1 (Fli-1) by Immunohistochemistry
  • Gastrin by Immunohistochemistry
  • Gastrin, Serum
  • Gastrointestinal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 16 Genes
  • Gastrointestinal Stromal Tumor Mutation
  • Glial Fibrillary Acidic Protein (GFAP) by Immunohistochemistry
  • Glucagon, Plasma
  • Glucose-6-Phosphate Dehydrogenase
  • Glypican 3 by Immunohistochemistry
  • Granzyme B by Immunohistochemistry
  • Growth Hormone, Serum or Plasma
  • HBME-1 (Mesothelial Cell) by Immunohistochemistry
  • Helicobacter pylori by Immunohistochemistry
  • Hepatocellular Carcinoma Tumor Marker Panel
  • Hepatocyte Specific Antigen (HSA) by Immunohistochemistry
  • HER-2/neu Quantitative by ELISA
  • Hereditary Paraganglioma-Pheochromocytoma (SDHB) Sequencing and Deletion/Duplication
  • Hereditary Paraganglioma-Pheochromocytoma (SDHB, SDHC, and SDHD) Deletion/Duplication
  • Hereditary Paraganglioma-Pheochromocytoma (SDHB, SDHC, and SDHD) Sequencing and Deletion/Duplication Panel
  • Hereditary Paraganglioma-Pheochromocytoma (SDHC) Sequencing and Deletion/Duplication
  • Hereditary Paraganglioma-Pheochromocytoma (SDHD) Sequencing and Deletion/Duplication
  • Herpes Virus 8 by Immunohistochemistry
  • HLA-B*5701 Associated Variant Genotyping for Abacavir Sensitivity
  • Melanoma Antibody, HMB45 by Immunohistochemistry
  • HNPCC/Lynch Syndrome (MLH1) Sequencing and Deletion/Duplication
  • HNPCC/Lynch Syndrome (MSH2) Sequencing and Deletion/Duplication
  • HNPCC/Lynch Syndrome (MSH6) Sequencing and Deletion/Duplication
  • HNPCC/Lynch Syndrome (PMS2) Sequencing and Deletion/Duplication
  • HNPCC/Lynch Syndrome Deletion/Duplication
  • Homovanillic Acid (HVA), Urine
  • HRAS Mutation Detection by Pyrosequencing
  • Human Chorionic Gonadotropin (Beta-hCG) by Immunohistochemistry
  • Human Epididymis Protein 4 (HE4)
  • Growth Hormone by Immunohistochemistry
  • Human Papillomavirus (HPV) 16 and 18 Genotype by PCR, SurePath
  • Human Papillomavirus (HPV) DNA Probe, High Risk, Cervical Brush
  • Human Papillomavirus (HPV) Genotypes 16 and 18/45, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
  • Human Papillomavirus (HPV) High Risk In Situ Hybridization, Paraffin
  • Human Papillomavirus (HPV) Low Risk by In Situ Hybridization, Paraffin
  • Human Papillomavirus (HPV), High Risk by Hybrid Capture (SurePath)
  • Human Papillomavirus (HPV), High Risk by Hybrid Capture, ThinPrep
  • Human Papillomavirus (HPV), High Risk by PCR, SurePath
  • Human Papillomavirus (HPV), High Risk by PCR, ThinPrep
  • Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, SurePath
  • Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, ThinPrep
  • Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
  • Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA) with Reflex to Genotypes 16 and 18/45
  • Human Placental Lactogen (HPL) by Immunohistochemistry
  • Human T-Lymphotrophic Virus Types I/II Antibodies, Western Blot
  • Human T-Lymphotropic Virus Types I/II Antibodies with Reflex to HTLV I/II Confirmation
  • IDH1 and IDH2 Mutation Analysis, exon 4
  • IDH1 R132H Point Mutation with Interpretation by Immunohistochemistry
  • IDH1R132H Mutation by Immunohistochemistry
  • IGF-1 (Insulin-Like Growth Factor 1)
  • IGH-BCL2 Fusion, t(14;18) by FISH for Detection in Follicular Lymphoma
  • IGH-CCND1 (BCL-1/JH) Translocation, t(11;14) by PCR
  • IGH-CCND1 Fusion, t(11;14) by FISH
  • IGH-MYC Fusion t(8;14) by FISH for Detection in Burkitt Lymphoma
  • IGHV Mutation Analysis by Sequencing
  • Immunofixation Electrophoresis Gel
  • Inhibin A (Dimer), Serum
  • Inhibin B, Serum
  • Inhibin by Immunohistochemistry
  • INI1 (BAF47) by Immunohistochemistry
  • Insulin, Fasting, Serum or Plasma
  • Interleukin 28 B (IL28B)—Associated Variants, 2SNPs
  • MUM1/IRF4 by Immunohistochemistry
  • JAK2 Exon 12 Mutation Analysis by PCR
  • JAK2 Gene, V617F Mutation, Qualitative
  • JAK2 Gene, V617F Mutation, Qualitative with Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR with Reflex to MPL codon 515 Mutation Detection by Pyrosequencing, Quantitative
  • JAK2 Gene, V617F Mutation, Qualitative with Reflex to JAK2 Exon 12 Mutation Analysis by PCR
  • JAK2 Gene, V617F Mutation, Quantitation
  • Juvenile Polyposis (BMPR1A) Sequencing
  • Juvenile Polyposis (SMAD4) Deletion/Duplication
  • Juvenile Polyposis (SMAD4) Sequencing
  • Juvenile Polyposis (SMAD4) Sequencing and Deletion/Duplication
  • Juvenile Polyposis Syndrome (BMPR1A) Deletion/Duplication
  • Kappa Light Chains by Immunohistochemistry
  • Kappa/Lambda Quantitative Free Light Chains with Ratio, Serum
  • Keratin 903 (K903) High Molecular Weight by Immunohistochemistry
  • Ki-67 with Interpretation by Immunohistochemistry
  • Ki-67, MIB1, by Immunohistochemistry
  • KIT Mutations in AML by Fragment Analysis and Sequencing
  • KIT Mutations, Melanoma
  • KRAS Mutation Detection
  • KRAS Mutation Detection with BRAF reflex
  • Lactate Dehydrogenase, Serum or Plasma
  • Lambda Light Chains by Immunohistochemistry
  • Leukemia/Lymphoma Phenotyping by Flow Cytometry
  • Leukemic Blood, Chromosome Analysis with Reflex to Genomic Microarray
  • Leukocyte Alkaline Phosphatase
  • Lipid Associated Sialic Acid, Serum
  • Lung Cancer Panel
  • Lung Cancer Panel with KRAS
  • Luteinizing Hormone, Serum
  • Lymphoma (Aggressive) Panel by FISH
  • Lysozyme, Urine
  • Macroprolactin, Serum or Plasma
  • Mast Cell Tryptase by Immunohistochemistry
  • MDM2 by Immunohistochemistry
  • MDM2 Gene Amplification by FISH
  • Melan A by Immunohistochemistry
  • Melanoma Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 6 Genes
  • MET Gene Amplification by FISH
  • Metanephrines, Plasma (Free)
  • Methylenetetrahydrofolate Reductase (MTHFR) 2 Mutations
  • MGMT Methylation Detection by PCR
  • Microsatellite Instability (MSI), HNPCC/Lynch Syndrome, by PCR
  • Mismatch Repair by Immunohistochemistry
  • Mismatch Repair by Immunohistochemistry with Reflex to BRAF Codon 600 Mutation and MLH1 Promoter Methylation
  • Mismatch Repair by Immunohistochemistry with Reflex to MLH1 Promoter Methylation
  • MITF by Immunohistochemistry
  • MLH1 Promoter Methylation, Paraffin
  • Molar Pregnancy, 16 DNA Markers
  • Motor and Sensory Neuropathy Evaluation with Immunofixation Electrophoresis and Reflex to Titer and Neuronal Immunoblot
  • Motor and Sensory Neuropathy Evaluation with Reflex to Titer and Neuronal Immunoblot
  • Motor Neuropathy Panel
  • MPL codon 515 Mutation Detection by Pyrosequencing, Quantitative
  • Muc-1 by Immunohistochemistry
  • Muc-4 by Immunohistochemistry
  • Muc-5AC by Immunohistochemistry
  • Multiple Endocrine Neoplasia Type 2 (MEN2), RET Gene Mutations by Sequencing
  • Multiple Myeloma Panel by FISH
  • Muscle-Specific Actin (MSA) by Immunohistochemistry
  • MUTYH-Associated Polyposis (MUTYH) 2 Mutations
  • MYC (8q24) Gene Rearrangement by FISH
  • MYCN (N-MYC) Gene Amplification by FISH
  • MYD88 L265P Mutation Detection by PCR, Quantitative
  • Myelodysplastic Syndrome (MDS) Panel by FISH
  • Myeloid Malignancies Mutation Panel by Next Generation Sequencing
  • Myeloid Malignancies Somatic Mutation and Copy Number Analysis Panel
  • Myeloperoxidase (MPO) by Immunohistochemistry
  • Myeloproliferative Disorders Panel by FISH
  • Myogenin (Myf4) by Immunohistochemistry
  • Myoglobin by Immunohistochemistry
  • Myosin by Immunohistochemistry
  • Napsin A by Immunohistochemistry
  • Neurofilament by Immunohistochemistry
  • Neuron Specific Enolase, CSF
  • Neuron Specific Enolase, Polyclonal (NSE P) by Immunohistochemistry
  • Neuron Specific Enolase, Serum
  • Neuronal Nuclear (Hu, Ri, Yo, and Amphiphysin) Antibodies IgG by Immunoblot
  • Neuronal Nuclear Antibodies (ANNA) IgG, Immunoblot, Serum
  • Neuronal Nuclear Antibody (ANNA) IgG by IFA with Reflex to Titer and Immunoblot,
  • Neuronal Nuclear Antibody (ANNA) Titer IgG by IFA, Serum
  • Neuronal Nuclei (NeuN) by Immunohistochemistry
  • NMP22®
  • NPM1 Mutation by PCR and Fragment Analysis
  • NRAS Mutation Detection by Pyrosequencing
  • Octamer Transcription Factor-2 (Oct 2) by Immunohistochemistry
  • Octamer Transcription Factor-3 and -4 (Oct 3/4) by Immunohistochemistry
  • Opioid Receptor, Mu (OPRM1) Genotype, 1 Variant
  • p16 by Immunohistochemistry
  • p21 (Waf1/Cip 1) by Immunohistochemistry
  • P504S (AMACR) by Immunohistochemistry
  • p53 by Immunohistochemistry
  • p53 with Interpretation by Immunohistochemistry
  • p63 by Immunohistochemistry
  • Pancreatic Polypeptide, Serum
  • Pancreatitis, (PRSS1) Sequencing
  • Pancreatobiliary FISH
  • Parathyroid Hormone (PTH) by Immunohistochemistry
  • Parathyroid Hormone, Intact with Calcium
  • Parathyroid Hormone, Intact, Serum or Plasma
  • Parathyroid Hormone-Related Peptide (PTHrP)
  • Plasma
  • Whole Blood
  • Pax-5 by Immunohistochemistry
  • PAX8 by Immunohistochemistry
  • PAX8-PPARG Translocations Detection by PCR
  • PCA3 - Prostate Cancer Biomarker by Transcription-Mediated Amplification
  • PD-1 by Immunohistochemistry with Interpretation
  • PD-L1 22C3 pharmaDx by Immunohistochemistry with Interpretation, pembrolizumab (KEYTRUDA)
  • PD-L1 28-8 pharmDx by Immunohistochemistry with Interpretation, nivolumab (OPDIVO)
  • Peutz-Jeghers Syndrome (STK11) Deletion/Duplication
  • Peutz-Jeghers Syndrome (STK11) Sequencing
  • Peutz-Jeghers Syndrome (STK11) Sequencing and Deletion/Duplication
  • PIK3CA Mutation Detection
  • Placental Alkaline Phosphatase (PLAP) by Immunohistochemistry
  • PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative
  • PML/RARα Translocation by FISH
  • Procollagen Type I Intact N-Terminal Propeptide, Serum
  • Progesterone Receptor (PR) by Immunohistochemistry
  • Proinsulin
  • Proinsulin/Insulin Ratio
  • Prolactin by Immunohistochemistry
  • Prolactin Macroadenoma, Serum or Plasma
  • Prolactin, Serum or Plasma
  • Prosigna Breast Cancer Prognostic Gene Signature
  • Prostate Specific Antigen by Immunohistochemistry
  • Prostate Specific Antigen, Complexed
  • Prostate Specific Antigen, Free Percentage (includes Free PSA and Total PSA), Serum or Plasma
  • Prostate Specific Antigen, Total - Medicare Screening
  • Prostate Specific Antigen, Total with Reflex to Free PSA (includes Free
  • Prostate Specific Antigen, Total, Serum or Plasma
  • Prostate Specific Antigen, Ultrasensitive, Serum or Plasma
  • Prostatic Acid Phosphatase
  • Prostatic Acid Phosphatase (PAP) by Immunohistochemistry
  • Protein Electrophoresis with Reflex to Immunofixation Electrophoresis Monoclonal Protein Detection, Quantitation and Characterization, IgA, IgG, & IgM, Serum
  • Protein Electrophoresis, CSF
  • Protein Gene Product (PGP) 9.5 by Immunohistochemistry
  • PTEN by Immunohistochemistry
  • PTEN with Interpretation by Immunohistochemistry
  • Purkinje Cell Cytoplasmic Antibody by IFA with Reflex to Titer and Immunoblot, Serum
  • Raji Cell Immune Complex Assay, Serum
  • RBC Band 3 Protein Reduction in Hereditary Spherocytosis
  • Renal Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes
  • RET Gene Rearrangements by FISH
  • RET-CCDC6 and RET-NCOA4 (RET-PTC1 and RET-PTC3) Translocations Detection by PCR
  • Risk of Ovarian Malignancy Algorithm
  • ROS1 by FISH
  • ROS1 with Interpretation by Immunohistochemistry with Reflex to FISH if Equivocal
  • RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Detection, Quantitative
  • S-100 Protein by Immunohistochemistry
  • S-100B Protein, Serum
  • SDHB with Interpretation by Immunohistochemistry
  • Sensory Neuropathy Antibody Panel with Reflex to Titer and Neuronal Western Blot
  • Serotonin, Serum
  • Serotonin, Whole Blood
  • Sezary Cell Exam
  • Smooth Muscle Actin (SMA) by Immunohistochemistry
  • Solid Tumor Mutation Panel by Next Generation Sequencing
  • Soluble Mesothelin Related peptides (MESOMARK®), Serum
  • Somatostatin, Plasma
  • Special Stain, Periodic Acid-Schiff (PAS)
  • Squamous Cell Carcinoma Antigen, Serum
  • SS18 (SYT) (18q11) Gene Rearrangement by FISH
  • Synaptophysin by Immunohistochemistry
  • T-Cell Clonality by Flow Cytometry Analysis of TCR V-Beta
  • T-Cell Clonality by Next Generation Sequencing
  • T-Cell Clonality Screening by PCR
  • T-cell Intracytoplasmic Antigen (TIA-1) by Immunohistochemistry
  • Tartrate-Resistant Acid Phosphatase (TRAP) by Immunohistochemistry
  • TdT by Immunohistochemistry
  • Testosterone, Females or Children
  • Thiopurine Methyltransferase (TPMT) Genotyping, 4 Variants
  • Thiopurine Methyltransferase, RBC
  • Thyroglobulin Antibody
  • Thyroglobulin by Immunohistochemistry
  • Thyroglobulin by LC-MS/MS, Serum or Plasma
  • Thyroglobulin, Fine Needle Aspiration (FNA)
  • Thyroid Stimulating Hormone, Serum or Plasma
  • Thyroid Transcription Factor (TTF-1) by Immunohistochemistry
  • Thyroid Translocation and Mutation Panel
  • Tumor Necrosis Factor, Alpha, Serum or Plasma
  • UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping
  • Ulex Europaeus Agglutinin 1 (UEA-1) by Immunohistochemistry
  • UroVysion FISH
  • Vanillylmandelic Acid (VMA) & Homovanillic Acid (HVA), Urine
  • Vanillylmandelic Acid (VMA), Urine
  • Vasoactive Intestinal Peptide, Plasma
  • Vimentin by Immunohistochemistry
  • Viscosity, Serum
  • Vitamin D, 1, 25-Dihydroxy, Serum or Plasma
  • Warfarin Sensitivity, CYP2C9 & VKORC1, 3 Variants
  • Wilms Tumor (WT1), N-terminus by Immunohistochemistry
  • WT1 Mutation Detection by Sequencing
  • ZAP-70 Analysis by Flow Cytometry

Leave a Reply

Your email address will not be published. Required fields are marked *

six − one =

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>